USA - Consumable well plates for NCATS robotic high-throughput systems - Axion BioSystems

For more information and to make a bid you will need to go to the third party website.


Provided by Open Opps
Opportunity closing date
12 July 2019
Opportunity publication date
04 July 2019
Value of contract
to be confirmed
Your guide to exporting
Report opportunity


Added: Jul 03, 2019 1:01 pm

Title: Consumable well plates for NCATS robotic high-throughput systems -Axion BioSystems
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(ii) The solicitation number is 75N95019Q00153 and the solicitation is issued as a request for quotation (RFQ).
This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures and FAR Part 12-Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold.
The National Institute on Drug Abuse (NIDA), NIDA Office of Acquisitions - NCATS Section, on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Axion BioSystems, Inc., 1819 Peachtree Road NE, Suite 350, Atlanta, GA 30309, for Lumos MEA well plates for use with the Axion BioSystems Maestro MEA system.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2019-2 dated 6/5/2019.
(iv) The associated NAICS code is 334516 and the small business size standard is 1000 employees. No set-aside restriction is applicable.
(v) The acquisition consists of:
1. Lumos MEA 48 plate, 16 microelectrodes per well, 68 cases of 5 plates each.
(vi) Delivery shall be to:
The National Center for Advancing Translational Sciences (NCATS)
9800 Medical Center Drive
Rockville, MD 20850
Delivery shall be within 15 days after receipt of order, FOB destination. Shipping costs, if any, must be stated in the quote.
(vii) The provision at FAR clause 52.212-1, Instructions to Offerors - Commercial Items, applies to this acquisition.
     CONTENTS OF THE QUOTE (to be provided by the Offeror, or presented on Offeror's standard quotation form): 
     1. Name of Company.
     2. Street Address, City, State, Zip code.
     3. Name of Person, telephone number, and e-mail address of person authorized to provide quote.
     4. DUNS number.
     5. Period of Performance OR Delivery Date After Receipt of Order.
     6. Contract number (and title) if quoting based on a contract vehicle other than open market (such as GSA Federal Supply Schedules; other Government agency (OGA) contracts, Government-wide Acquisition Contracts (GWACs); or National Institute of Health (NIH) Blanket Purchase Agreements (BPA)).
     7. Technical description of the product or service offered, in sufficient detail to evaluate compliance with the requirements of the Product Description above. Provide product or catalog number(s); product or service description, list price, unit price, unit discounts, total price, any shipping and handling costs, country of origin, etc.
     8. Shipping costs and terms (f.o.b. and other terms as applicable).
     9. Payment discount terms.
     10. Any other information or factors that may be considered in the award decision. Such factors may include: past performance; special features required for effective program performance; trade-in considerations; probable life of the item selected as compared with that of a comparable item; warranty considerations; maintenance availability; and environmental and energy efficiency considerations.
(viii) Offers will be evaluated for technical criteria, price, and past performance. Technical criteria consist of matching the line items identified above. Technical and past performance, when combined, are significantly more important than price.
(ix) Offerors are to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items, with offers.
(x) The FAR clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. The following addendum applies:
The following FAR provisions or clauses are incorporated by reference:
52.204-7, System for Award Management (Oct 2018)
52.204-13, System for Award Management Maintenance (Oct 2018)
52.204-16, Commercial and Entity Code Reporting (Jul 2016)
52.204-18, Commercial and Entity Code Maintenance (Jul 2016)
HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015).
52.212-4(g), Invoice, is supplemented by the NIH Invoice and Payment Instructions (2/2014).
(xi) FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition.
(xii) This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this solicitation must include sufficient information to establish the interested parties' bona-fide capabilities of providing the product.
A determination by the Government whether to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered to determine whether to proceed on a non-competitive basis as indicated above, or to conduct a competitive procurement.
(xiii) In addition, the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM)
All responses must be received by 11:00 a.m. on Friday, July 12, 2019, and reference solicitation number 75N95019Q00153. Responses must be submitted by email to Stuart Kern, Contract Specialist,, 301-402-3334.

Opportunity closing date
12 July 2019
Value of contract
to be confirmed

About the buyer

Department of Health and Human Services National Institute on Drug Abuse United States

The deadline to apply for this opportunity has passed.
Visit the opportunities page to find another.

Is there anything wrong with this page?